Alpha Teknova, Inc.

Alpha Teknova, Inc. is a leading producer of critical reagents used in the discovery, development, and commercialization of new therapies, vaccines, and molecular diagnostics. The company serves over 3,000 customers across the life sciences market, including major pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Teknova's business relies on its adaptable and configurable manufacturing processes and infrastructure. These proprietary processes allow the company to produce and deliver high-quality, custom, made-to-order products quickly and at scale, supporting customers through all stages of product development, including commercialization. With over two decades of expertise in raw material sourcing, chemical formulation, and quality control, Teknova can typically move a new custom product into production within weeks of receiving an order. This allows customers to receive products in weeks, compared to months from alternative suppliers. The company's processes are designed to handle diverse customer requirements, including variations in volume, chemical formulation, quality specifications, container types, and transportation needs, enabling broad application of its products across the life sciences market. Teknova offers three main product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The company typically begins working with customers during the discovery phase, where they use Teknova's off-the-shelf (catalog) formulations for initial experiments.